Cannaspirations Episode 7: Cannabis Rescheduling, Intoxicating Hemp Bans & Expert Witness Testimony

Welcome back to Cannaspirations, Cannaspire’s educational series covering the most important legal, regulatory, and compliance issues shaping the cannabis industry. In this episode, Cannaspire’s Chief Compliance Officer Warren Harasz and Director of Compliance Beck Selman are joined by Natalie Diaz of Mandelbaum Barrett PC and cannabis testing laboratory expert Jimmy Dodsworth to discuss recent federal activity around cannabis rescheduling and the upcoming intoxicating hemp product bans. The conversation focuses on the growing role of expert witness testimony in cannabis and hemp-related cases, including regulatory compliance disputes, THC testing challenges, DUI and impairment cases, and emerging state versus federal enforcement conflicts. This episode is designed for cannabis operators, attorneys, compliance professionals, investors, regulators, and anyone navigating hemp-derived THC enforcement and evolving federal oversight. Topics covered: • Federal cannabis rescheduling and industry impact • Intoxicating hemp bans, Delta-8, and enforcement risk • When and why expert witnesses are used in cannabis cases • Hemp vs marijuana THC thresholds and lab testing disputes • Certificates of Analysis (COAs), error rates, and reasonable doubt • State vs federal cannabis and hemp regulatory conflicts • Expected litigation following intoxicating hemp bans Disclaimer: This content is for educational and informational purposes only and does not constitute legal advice.